We analyzed seven Streptococcus pneumoniae serogroup 35 isolates by pulsed-field gel electrophoresis of the genome and pbp2b gene nucleotide sequences. Three penicillin-susceptible strains and one penicillin-intermediate-resistant strain exhibited 100% identity to prototype R6. Two resistant strains and one other intermediate strain differed from them and contained a unique sequence.
Penicillin-nonsusceptible Streptococcus pneumoniae (PNSP) remains a major global health threat because S. pneumoniae is the predominant bacterial pathogen of community-acquired pneumonia and a major cause of meningitis and of otitis media in children (1, 2, 8, 9, 17, 20, 22, 23, 26, 27, 32, 33, 35, 37) . S. pneumoniae develops penicillin resistance through recombination with other penicillin-resistant S. pneumoniae (PRSP) strains or closely related streptococcal species that alter its penicillin binding protein (pbp) genes pbp1a, pbp2b, and pbp2x (5, 10, 13, 19) . These altered pbp gene sequences of PNSP differ greatly within the PNSP subset and from the sequences of penicillin-susceptible S. pneumoniae (PSSP) (4, 5, 11, 12, 13, 19, 34, 38, 40) .
Serogroups/types (SGTs) 6, 9, 14, 19, and 23 are the most common SGTs associated with penicillin resistance in the United States (15, 39) . PNSP strains of other SGTs have been recognized worldwide, especially serotype 35B (7, 15, 21, 25, 28, 29) . Between 1983 and 2005, we recovered seven SGT 35 isolates, three of which were PNSP, and other than the five common SGTs, they represented the only other PNSP SGTs in our community (30, 36) . Because serotype 35B emerged as a new resistant serotype, we investigated the clonal relationships between SGT 35 PSSP and PNSP strains by pulsed-field gel electrophoresis (PFGE) of the complete genome and pbp2b gene DNA sequences.
Strains. Seven SGT 35 strains (0.94%) were identified from a total of 741 invasive S. pneumoniae strains recovered between 1983 and 2005 from adults. Capsular type was determined by Quellung reaction and designated using the Danish nomenclature (3). Penicillin susceptibility was assessed by Etest (AB Biodisk). Susceptibility to other antibiotics was assessed by Etest or a disk diffusion test.
PCR, restriction fragment length polymorphism (RFLP), and PFGE. Genomic DNA from the seven isolates was extracted using a Qiagen DNeasy tissue kit. The pbp2b gene was amplified using the primers pbp2b-for (5ЈGATCCTCTAAAT GATT CTCAGGTGG CTGT3Ј) and pbp2b-rev (5ЈGTCAAT TAGCTTAGCAATAGGTGTTGGAT3Ј) and Invitrogen Platinum PCR SuperMix High Fidelity using reaction times as previously described by Beall et al. (6) . The PCR product was digested with HaeIII and HinfI (Invitrogen). Further comparison of the isolates was done by molecular subtyping of the complete genome. The genome was digested with SmaI and resolved using a PFGE technique described by McEllistrem et al. (24) .
DNA sequencing of the pbp2b gene. Six primers were used for DNA sequencing, the forward and reverse primers (see above) with 2 internal forward primers (5ЈTGCTGTTTTGTC TATGTCAGG3Ј and 5ЈACCTTTGGTGAATATGGTTTGG 3Ј) and 2 internal reverse primers (5ЈAGTTATCAAACTGC CCAAAGG3Ј and 5ЈACAAGACTCCATTTTCCCAAC3Ј) that we designed using SeqWeb. Dye terminator sequencing and analysis were completed using an ABI 3130 genetic analyzer. DNA sequences were aligned using multiple-sequence alignment by ClustalW version 1.83 (http://clustalw.genome.jp/). We compared for sequence identity our seven strains to each other, to the susceptible reference strain R6 (GenBank accession no. X16022), and to other strains registered with PubMed using the BLASTn program from NCBI (http://www.ncbi.nlm .nih.gov/Blast.cgi). The nucleotide sequences were translated into their corresponding amino acids, which were analyzed using the BLASTn program.
Probe analysis of the pbp2b gene. Strains were analyzed for the presence of the five oligonucleotide probes described by Dowson et al. (13) . Our strains contained only three of the five probes, namely, probe 1 from PSSP R6 (nucleotides 694 to 714), probe 2 from the PRSP DN87/577 strain (nucleotides 694 to 714), and probe 3 from penicillin-resistant Streptococcus oralis strains 5296 and 5302 (nucleotides 754 to 783). The inclusion of either probe 2 or probe 3 conferred nonsusceptibility (13) .
Comment. (Table 1) . However, there were no differences in amino acids between the SUSC group and R6 as a result of these nucleotide changes. Two PRSP strains (S1023 [35B] and S1044 [35B]) and one high-level-PISP strain (S1070 [35B]), designated the RESIST group, showed 100% sequence identity to each other (Table 1 ) and 92% to R6, differing by 115 nucleotides, which resulted in 20 amino acid differences from R6 (Table 1) .
The RESIST-group strains were susceptible to tetracycline, trimethoprim-sulfamethoxazole, ofloxacin, and chloramphenicol, with the exception of the PISP strain S1070, which was resistant to tetracycline. These strains were resistant to erythromycin and cefuroxime and intermediate resistant to imipenem and cefotaxime, with the exceptions of S1044 and S1023, which were susceptible to cefotaxime. Strain S0398, which exhibited lowlevel-intermediate resistance to penicillin, was susceptible to all other antibiotics tested.
Strains of the SUSC group showed two common HaeIII restriction sites, and the RESIST group showed these two sites and two additional common restriction sites (Fig. 1a) . Seven HinfI restriction sites were common to the SUSC group, and eight HinfI restriction sites were common to RESIST group strains (Fig. 1b) . Five of the HinfI restriction sites occurred in all seven strains, one of which was located in the forward primer. The SUSC group HinfI digestion resolved into four single bands and one double band, which was composed of 78-and 82-bp fragments; two bands smaller than 50 bp could not be identified. HinfI digestion of the RESIST group showed five bands, and four bands, each smaller than 50 bp, could not be identified (Fig. 1b) .
By BLASTn analyses, the pbp2b gene DNA sequence of the SUSC group strains showed 99% or 100% sequence identity to several strains in the PubMed database (12, 14, 16, 18) . The RESIST group showed 96% sequence identity with two strains registered in PubMed, SP00080 and SP00081 (31) . When amino acid sequences were compared, the RESIST group strains showed 99% identity to SP00080, 98% identity to SP00081, and 99% identity to unregistered strains J1 and J88 (4) .
Of the three oligonucleotide probes identified in our pbp2b genes, probe 1 was present only in SUSC group strains (4, 11, . Probes 2 and 3 were present only in RESIST group strains, both within a resistant block (618 to 891 bp), that contained 57 bp and 11 amino acid substitutions and resulted in 21% divergence from R6 ( Fig. 2) (13) . The RESIST group strains showed 100% sequence identity in this resistant region to the PRSP SP00091, S. oralis 5296, and Streptococcus mitis B6 strains and 99% sequence identity to Streptococcus sanguis 1907 and PRSP DN87/577 (Table 2) (11, 13, 31) . The pbp2b gene in the RESIST group strains contained a second resistant block that was not associated with PRSP probe 2. This second resistant nucleotide block, comprising nucleotides 1227 to 1458, diverged from R6 by 13.4% and represents a unique region not registered in the PubMed database. The two sensitive blocks, comprising nucleotides 1 to 617 and 892 to 1226, diverged from R6 by 3.2% and 2.1%, respectively. Nucleotides 1 to 1226 showed 98% sequence identity to several strains registered in the PubMed database, including DN87/577, but the complete 1.5-kb sequence showed a maximum identity of 96% to any strain registered in PubMed because of the unique resistant block comprising nucleotides 1227 to 1458, which showed no more than 86% identity to any registered sequence ( Table 2) .
The pbp2b gene sequences of the strains in the SUSC group were essentially indistinguishable from those of the reference PSSP strain R6 and the serotype 35N strain 2282 (GenBank accession no. DQ071921), identified by Granger et al. (18) . The PFGE analysis of the SUSC group showed that the three serotype 35F strains shared the same PFGE profile, which differed from the profile of the single serotype 35B strain (Fig. 3). FIG. 2. The 1.5-kb segment from the Streptococcus penicillin binding protein 2b gene and the percentages of nucleotide divergence from strain R6 of alternating susceptible (white) and resistant (black) blocks are illustrated. R6 is a penicillin-susceptible S. pneumoniae laboratory strain (GenBank accession no. X16022). Strains S1070/S1044/S1023 are penicillin-resistant S. pneumoniae (PRSP) serotype 35 strains with identical nucleotide sequences (S1070; MIC ϭ 1.000 g/ml). Results are shown for PRSP strain DN87/577, PRSP strain SP00091, penicillin-resistant S. sanguis strain 1907, penicillin-resistant S. mitis strain B6, and penicillin-resistant S. oralis strain 5296. 
a Only amino acids that differ from those of the PSSP strain R6 are shown; a dash indicates an amino acid identical to that of R6. 402 NOTES J. CLIN. MICROBIOL.
The pbp2b gene sequences of the strains in the RESIST group were identical to each other but showed no more than 96% sequence identity to any Streptococcus strain in the PubMed database. However, their amino acid sequences showed 100% sequence identity to each other and 99% sequence identity to a few published S. pneumoniae strains (4, 31). All three RESIST group serotype 35B strains showed identical restriction enzyme profiles of the pbp2b gene, which differed from those of the SUSC group. All RESIST group strains showed PFGE profiles identical to each other and to that of the resistant 35B strain identified by Beall et al., and it seems highly likely that the RESIST group strains originated from the same clone (7) . Based on the results of several studies worldwide, it appears that a high proportion of PNSP SGT 35 strains, including our RESIST group strains, were derived from this clone (7, 15, 21, 25, 28, 29) . However, the clone that circulated in our community possessed a unique nucleotide sequence (nucleotides 1227 to 1458) that differed from any sequence published in PubMed. The likelihood is that it acquired an altered sequence by recombination with existing Streptococcus strains prior to or after introduction into our community.
Institutional Review Board. This research study was approved by the Institutional Review Boards of Marshall University and of each of the affiliated hospitals.
